Prof. Annapurna Vyakarnam
PhD
Human Immunology Laboratory
Languages
English, Hindi, Kannada, Tamil
- Overview
- Projects
- Publications
- Other Contributions
Prof. Annapurna Vyakarnam holds a dual academic affiliation: Professor of Microbial Immunology at King’s College London and Adjunct Professor at St. John’s Research Institute, India, where she heads the Human Immunology Laboratory within the Division of Infectious Diseases, which is led by Professor M. Dias
Qualification: BSc Hons (Pune University, India); MSc (Uni. London, UK); PhD (Cambridge University, UK).
Email: annapurna.2.vyakarnam@kcl.ac.uk, annapurna.v@sjri.res.in
Dr Vyakarnam’s laboratory focuses on the immunology of acute and persistent respiratory infections that pose global health challenges in adults, infants and the vulnerable (the elderly, subjects with type 2 diabetes and with defined cardiovascular risk) to understand how and why the immune response changes in subjects who fall into these vulnerable categories. Her laboratory uses cellular, molecular, immunological, and functional genomic approaches to conduct an in-depth functional analysis of innate and adaptive immune responses in primary clinical samples. In the past nine years she has set up an active wet laboratory research programme with colleagues at St John’s Research Institute, Bangalore, India, focussed on longitudinal human immune profiling studies using an integrated systems approach to understand heterogeneity, persistence and linked T cell receptor diversity of pathogen-specific immune responses to SARS-CoV-2, influenza, and Mycobacterium tuberculosis (Mtb) (with and without HIV coinfection) during the symptomatic infection phase, recovery phase, contextualised with immune responses induced by current and emerging vaccines to the same pathogens in healthy and potentially immunocompromised subjects.
An important focus of her laboratory is to understand mechanisms of immune training, which is vital for both innate and adaptive immune defence using Bacillus Calmette Guerin (BCG) as a modulating tool. Her laboratory has published extensively on how BCG revaccination through chromatin remodelling can be used as a tool to diversify pathogen-directed innate and heterologous adaptive responses to influenza and SARS-CoV-2 vaccines as part of a wider strategy to combat infections of global health importance. Dr Vyakarnam’s laboratory is also elucidating mechanistic pathways linked to newborn immunity and how these can be enhanced through BCG vaccination at birth combined with correcting profound vitamin D deficiency of the mother, through supplementation.
More recently her laboratory has initiated translational studies on T-cell therapy with colleagues, with the aim of reversing disease in the immunocompromised caused by opportunistic microbes due to holes in the T cell repertoire. Her laboratory is engaged in setting up detailed protocols to expand T cells specific to a panel of common viruses and to use systems approaches to characterise the expanded T-cells, as a basis for such cells being used as a therapeutic.
Dr Vyakarnam’s funding support comes from the Department of Biotechnology (DBT) India; Biotechnology Industry Research Assistance Council (BIRAC), India; MRC UKRI UK International funding; DBT India - MRC UK Joint COVID19 Funding; Wellcome Trust UK International Collaborative Grant Funding; DBT India - NIH USA Joint International funding; Corporate Social Responsibility (CSR), Govt. India support from Hindustan Unilever Ltd, India and the European Union (EU) - DBT joint International funding.
Key collaborators with joint grants and publications in the past 5 years
- Prof. Tom H. Ottenoff: Infectious Diseases, Leiden University Medical Centre, Leiden University, The Netherlands
- Dr Simone A. Joosten: Leiden University Medical Centre, Leiden University, The Netherlands
- Prof. Mihai Netea: Department of Immunology and Metabolism, Radbound University, The Netherlands
- Prof. Gagandeep Kang: Christian Medical Centre, Vellore, India
- Prof. Satyajit Mayor: National Centre of Biological Sciences, Bangalore, India
- Prof. L.S. Sashidhara: National Centre of Biological Sciences, Bangalore, India
- Prof. Catherine Hawrylowicz: School of Immunology and Microbial Sciences, King’s College London, London, UK
- Prof. Adrian Hayday: Department of Immunobiology, King’s College London, London, UK
- Prof. Stuart Neil: Department of Infectious Diseases, King’s College London, London, UK
- Prof. Ajay Shah: School of Cardiovascular Medicine & Sciences, King’s College London, London, UK
- Prof. Philip Chowienczyk: School of Cardiovascular Medicine & Sciences, King’s College London, London, UK
- Prof. Michael M. Malim: Department of Infectious Diseases, King’s College London, UK
- Prof. Wendy Barclay: Department of Infectious Diseases, Imperial College, London, UK
- Prof. Amit Singh: Centre for Infectious Disease Research, Indian Institute of Science, Bangalore, India
- Dr. Sudha Rao (Industry collaborator): Genotypic Technology Pvt Ltd, Bangalore, India
- Prof. George D’Souza: St. John’s Medical College and Hospital, Bangalore, India
- Dr Mary Dias: Department of Microbiology, St. John’s Research Institute, Bangalore, India
- Dr Pratibha Dwarkanath: Division of Nutrition, St. John’s Medical College and Hospital, Bangalore, India
- Prof. Stephen D’Rosa: Fred Hutchinson Cancer Research Centre, Seattle, Washington,
- Prof. Julie McElrath: University of Washington School of Medicine, Seattle, Washington
- Prof. Rajiv Khanna: Tumour Immunology Laboratory, Queensland Institute of Medical Research, Australia
- Prof. Alok Srivastava: Department of Clinical Haematology, St. John’s Research Institute, India
Laboratory Members and Capacity Building in Human Immunology
Current Staff:
Dr Asma Ahmed, Assistant Professor, Immunologist (DBT-BioCare Fellowship)
Mr Vasista Adiga, Project Scientist C and PhD student (Wellcome Trust award); Immunologist
Dr Sujitha Mary, Postdoctoral Research Assistant (Wellcome Trust award); Senior Bioinformatician
Dr Kiran B. K., Research Associate III (DBT-EU Award); Immunology
Ms Nirutha Chetan Kumar, Senior Project Associate, PhD student (Wellcome Trust award); Immunology
Ms Umalasya Hande, Senior Project Associate (DBT-EU Award); Molecular Immunology
Ms Bhavyashree N., Project Associate I (DBT-EU Award); Immunology
Ms Deekshitha M., Project Associate I (Wellcome Trust award); Microbiology
Recent Alumni:
Dr Himanshu Tripathi: Currently working in ExcelRa (Data Infrastructure and Analytics)
Dr Srabanti Rakshit: Currently works as a Consultant, Tata Institute of Genetics and Society, National Centre for Biological Sciences, India.
Ms Hima Bindhu: Currently works as a Specialist, Q-Gen Cell Therapeutics at Queensland Institute of Medical Research, Australia.
Dr Arunachalam Ramaiah: Currently works as a Director of Bioinformatics & Pathogen Genomics Centre of Excellence at the Georgia Department of Public Health, United States.
Open Positions
Actively recruiting for a Senior Immunologist post.
We are looking for a highly motivated immunologist to join our team (either recently completed their doctoral training in immunology or with experience) with interests in understanding the nature of immune responses during the course of natural respiratory tract infections and post-vaccination. We are interested to hear from individuals who have worked on either B-cells, T-cells or innate cell responses in animal models and/or human systems. Those interested, please write to Prof. Vyakarnam (annpurna.v@sjri.res.in) with a CV and a brief statement of research interests.
No experience details available.
No areas of interest specified.
No groups and associations specified.
Relationship Between Total 25-Hydroxyvitamin D and Parathyroid Hormone Concentrations During Early Gestation in Indian Women
Influenza vaccination post-COVID-19 expands vaccine-specific effector CD4 T-cells and Tregs under positive influence of host trained innate immunity
BCG vaccination-induced acquired control of mycobacterial growth differs from growth control preexisting to BCG vaccination
Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observational study.
Immune profiling reveals umbilical cord blood mononuclear cells from South India display an IL-8 dominant, CXCL-10 deficient polyfunctional monocyte response to pathogen-associated molecular patterns that is distinct from adult blood cells
Differences in Immune Responses in Individuals of Indian and European Origin: Relevance for the COVID-19 Pandemic
Polyfunctional CD4 T-cells correlating with neutralising antibody is a hallmark of COVISHIELDTM and COVAXIN® induced immunity in COVID-19 exposed Indians
BCG revaccination in adults enhances pro-inflammatory markers of trained immunity along with anti-inflammatory pathways
Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults
Hydrogen sulfide blocks HIV rebound by maintaining mitochondrial bioenergetics and redox homeostasis
A century of BCG: Impact on tuberculosis control and beyond
Emerging patterns of regulatory T cell function in tuberculosis
Innate immune mechanisms to oral pathogens in oral mucosa of HIV-infected individuals
HIV Skews a Balanced Mtb-Specific Th17 Response in Latent Tuberculosis Subjects to a Pro-inflammatory Profile Independent of Viral Load
BCG revaccination boosts adaptive polyfunctional Th1/Th17 and innate effectors in IGRA+ and IGRA- Indian adults
Evidence for highly variable, region-specific patterns of T-cell epitope mutations accumulating in Mycobacterium tuberculosis strains
Circulating HLA-DR+CD4+ effector memory T cells resistant to CCR5 and PD-L1 mediated suppression compromise regulatory T cell function in tuberculosis
Circulating Mycobacterium tuberculosis DosR latency antigen-specific, polyfunctional, regulatory IL10+ Th17 CD4 T-cells differentiate latent from active tuberculosis
Deep sequencing of near full-length HIV-1 genomes from plasma identifies circulating subtype C and infrequent occurrence of AC recombinant form in Southern India
HIV-TB co-infection: mechanisms that drive reactivation of Mycobacterium tuberculosis in HIV infection
Unbiased Identification of Blood-based Biomarkers for Pulmonary Tuberculosis by Modeling and Mining Molecular Interaction Networks
No Others Contributions details available.